Last reviewed · How we verify

NaCl 3% — Competitive Intelligence Brief

NaCl 3% (NaCl 3%) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Osmotic agent / Hypertonic saline. Area: Neurology / Critical Care.

phase 3 Osmotic agent / Hypertonic saline Neurology / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

NaCl 3% (NaCl 3%) — Raphaelle Jaquet-Pilloud. Hypertonic saline (3% NaCl) increases serum osmolality to draw fluid from intracellular and interstitial spaces into the intravascular compartment, reducing cerebral edema and intracranial pressure.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
NaCl 3% TARGET NaCl 3% Raphaelle Jaquet-Pilloud phase 3 Osmotic agent / Hypertonic saline
HSS 3% HSS 3% Ministry of Health, Spain phase 3 Osmotic agent / Hypertonic saline

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Osmotic agent / Hypertonic saline class)

  1. Ministry of Health, Spain · 1 drug in this class
  2. Raphaelle Jaquet-Pilloud · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). NaCl 3% — Competitive Intelligence Brief. https://druglandscape.com/ci/nacl-3. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: